Perspectives on clinical translation of smart nanotherapeutics
- PMID: 23323552
- PMCID: PMC4560357
- DOI: 10.4155/tde.12.112
Perspectives on clinical translation of smart nanotherapeutics
References
-
- Jain RK. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev. 1990;9(3):253–66. - PubMed
-
- Nie S, et al. Nanotechnology applications in cancer. Annu Rev Biomed Eng. 2007;9:257–88. - PubMed
-
- Lukyanov AN, et al. Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice. Pharm Res. 2002;19(10):1424–9. - PubMed
-
- Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul. 2001;41:189–207. - PubMed
-
- Fernandez-Urrusuno R, et al. Evaluation of liver toxicological effects induced by polyalkylcyanoacrylate nanoparticles. Toxicol Appl Pharmacol. 1995;130(2):272–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources